SAN FRANCISCO--(BUSINESS WIRE)--Nov. 13, 2003--Convergence CT, a provider of software products and data services that improve the efficiency of clinical research and development for the pharmaceutical industry, today announced the release of its Inpatient Insight(TM) market research data warehouse. Inpatient Insight(TM) is designed to assist pharmaceutical companies, medical device developers, and biotechnology companies with the rapid analysis of drug utilization, product comparisons, and therapy patterns within hospital care settings.
Pharmaceutical companies ("pharma") previously only had access to insurance summary data and retail pharmacy databases but no actual clinical record data. Now for the first time, pharmas have insight into a hospital's current clinical data, down at the actual record level, through the use of Inpatient Insight(TM).
Convergence CT's Inpatient Insight(TM) consists of a HIPAA (Health Insurance Portability and Accountability Act) compliant, projectable, patient level clinical record data warehouse of hospital drug utilization, prescription pattern, and therapy information. Inpatient Insight(TM) contains detailed patient data that spans the multiple care settings within a hospital, and the individual patient's history of treatment therein. This comprehensive range of information and its integration with pharmaceutical use and laboratory data make for an extremely rich and more revealing data warehouse. Patient data is extracted directly from a hospital's clinical applications. This data is then normalized, de-identified, and integrated into Convergence CT's proprietary data warehouse.
Lambert Onuma, Convergence CT's CEO and President said, "Finally, product managers and researchers can analyze the actual drug utilization across all major diagnoses and procedures, from hospitals all across the United States."
Inpatient Insight(TM) provides in-depth, non-biased information on drug utilization and treatment patterns. Detailed patient-level data is available across various hospital care settings and departments including inpatient, outpatient, emergency room, laboratory, and pharmacy, and follows the patient through those settings. This is the most complete repository of hospital clinical and drug utilization data available on the market today.
Convergence CT's mission is to provide the pharmaceutical and healthcare industry with software products and data services that improve the efficiency of the clinical development process. The company accomplishes this by combining the power of modern information technology with knowledge of the procedures necessary to protect the privacy of patients in the utilization of health data for research purposes.
Convergence CT is headquartered in San Francisco, California with offices in Honolulu, Hawaii and Tokyo, Japan.
For more information contact Convergence CT at 925/577-4035, or visit the company's website at http://www.convergencect.com.
Convergence CT Rob Albertson, 925-577-4035 http://www.convergencect.com
Source: Convergence CT